Stroke rehabilitation is a rapidly evolving field of research, and so it is necessary to periodically re-evaluate what constitutes state-of-the-art in stroke rehabilitation practices.
Rehab Science Blog + Patient Resource
Articles posted in March, 2014
Early research suggests that the FDA approved drug “Pletal” (cilostazol) may also have the potential to help treat lymphedema. Cilostazol (sold under the brand name “Pletal”) is drug that inhibits platelet aggregation and increases peripheral vasodilation. It is approved in the U.S. for the treatment of muscle pain during walking…